A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas
Clinical trial NCT01284231 · COMPLETED
Trial details
- NCT number
- NCT01284231
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2015-01-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.